Gevorg Tamamyan: If You are Visible on OncoDaily, You are Visible in Oncology
Aug 11, 2026
View online
Gevorg Tamamyan: If You are Visible on OncoDaily, You are Visible in Oncology
PSMAddition: [177Lu]Lu-PSMA-617 Improves Radiographic PFS in PSMA-Positive mAPMN/S Prostate Cancer
Ada Waks: Therapeutic Strategy for CDK4/6i-Resistant HR+ Metastatic Breast Cancer
Jim Yong Kim Joins ImmunityBio as Vice Chairman
Nazik Hammad: How Does Africa Produce Its Medical Oncology Workforce Locally?
Two Worlds, One Mission How a Canada–Nepal Partnership Is Transforming Global Oncology Education
HPV Vaccination After Cervical Intraepithelial Neoplasia: A New Era of Prevention in Brazil
Immunõ 2026: Global Virtual Congress on Immuno Oncology
Inova Hematology and Oncology Fellowship 2027
ONS Congress Scholarship 2027
7th Global Cancer Summit (GCS 2026)
IOS 2026 Best of ASCO
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
![PSMAddition: [177Lu]Lu-PSMA-617 Improves Radiographic PFS in PSMA-Positive mAPMN/S Prostate Cancer](https://oncodaily.com/pub/uploads/2026/08/PSMAddition-1280x720.webp)
